IPCA Laboratories

Market Cap (₹ Cr.)

₹38,893

52 Week High

1,708.65

Book Value

₹250

52 Week Low

1,041.00

PE Ratio

57.90

PB Ratio

5.80

PE for Sector

41.08

PB for Sector

4.17

ROE

6.85 %

ROCE

17.64 %

Dividend Yield

0.26 %

EPS

₹23.14

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

22.92 %

Net Income Growth

7.58 %

Cash Flow Change

17.23 %

ROE

-17.67 %

ROCE

-23.34 %

EBITDA Margin (Avg.)

11.80 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	664	762	752	691	640	860	891	756	673	719	875	870	794	868	1,012	960	848	1,030	1,227	1,157	1,018	1,497	1,313	1,331	1,061	1,492	1,439	1,342	1,190	1,496	1,530	1,464	1,435	1,530	1,699	1,524	1,526	1,581	1,828
Expenses	594	687	686	597	573	735	749	644	598	691	715	698	673	740	825	716	659	816	951	874	812	897	938	966	824	1,085	1,065	1,017	996	1,223	1,225	1,229	1,226	1,189	1,354	1,234	1,313	1,213	1,409
EBITDA	71	75	66	94	67	125	141	112	74	28	160	172	121	128	187	244	189	215	276	283	206	600	375	365	237	408	374	325	195	273	306	235	209	341	345	290	213	369	419
Operating Profit %	5 %	8 %	7 %	11 %	9 %	14 %	15 %	14 %	11 %	3 %	17 %	19 %	14 %	13 %	17 %	24 %	21 %	19 %	22 %	23 %	19 %	40 %	28 %	27 %	21 %	27 %	25 %	23 %	15 %	17 %	18 %	15 %	13 %	20 %	19 %	18 %	13 %	23 %	22 %
Depreciation	44	40	37	40	44	42	43	43	43	43	44	44	43	45	43	43	42	42	45	46	45	45	46	48	49	50	51	51	54	55	56	58	59	60	61	63	62	61	63
Interest	8	6	7	9	7	6	6	5	6	6	6	6	6	5	2	5	6	5	4	4	4	3	2	2	2	1	2	1	3	7	9	10	18	31	39	27	24	19	17
Profit Before Tax	18	29	22	45	16	77	92	64	26	-21	110	123	72	78	141	197	141	168	227	233	157	552	327	315	186	356	322	272	137	211	240	167	132	250	245	200	127	288	339
Tax	0	6	5	10	1	16	21	14	5	0	19	26	14	16	26	42	31	37	33	41	28	102	52	55	36	63	56	48	31	60	74	51	39	80	84	62	62	81	95
Net Profit	17	21	12	26	33	48	55	41	44	-20	97	106	51	66	120	160	110	132	196	197	128	454	276	260	152	285	258	218	110	140	166	115	85	167	162	137	65	204	244
EPS in ₹	1.31	1.66	0.98	2.09	2.61	3.77	4.35	3.28	3.52	-1.60	7.64	8.37	4.07	5.19	9.48	12.68	8.67	10.45	15.51	15.56	10.11	35.90	21.79	20.49	11.94	22.45	20.31	8.60	4.34	5.67	6.53	4.54	3.34	6.57	6.39	5.40	2.55	8.05	9.62

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	3,824	3,905	3,968	4,108	4,458	5,185	6,010	7,438	8,447	8,659
Fixed Assets	1,753	1,977	1,946	1,855	1,740	1,841	1,869	2,153	2,479	2,524
Current Assets	1,593	1,600	1,712	1,907	2,286	2,712	3,278	4,225	4,875	3,510
Capital Work in Progress	267	129	95	73	66	84	182	297	123	175
Investments	0	97	212	216	322	649	868	1,339	1,057	2,654
Other Assets	1,804	1,702	1,716	1,964	2,329	2,611	3,092	3,650	4,789	3,306
Total Liabilities	3,824	3,905	3,968	4,108	4,458	5,185	6,010	7,438	8,447	8,659
Current Liabilities	894	960	946	993	1,014	1,242	1,066	1,354	1,678	1,520
Non Current Liabilities	697	662	547	420	307	265	192	609	892	790
Total Equity	2,233	2,283	2,475	2,695	3,137	3,678	4,753	5,476	5,877	6,349
Reserve & Surplus	2,208	2,258	2,450	2,670	3,111	3,640	4,727	5,450	5,852	6,323
Share Capital	25	25	25	25	25	25	25	25	25	25

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	25	68	-31	74	150	-76	229	446	559	-990
Investing Activities	-686	-214	-146	-119	-123	-499	-560	-812	-710	-1,355
Operating Activities	455	696	271	324	496	561	1,096	832	762	831
Financing Activities	255	-414	-156	-130	-223	-139	-307	426	506	-465

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.30 %	46.30 %	46.30 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.02 %	0.02 %	0.02 %	0.00 %	9.86 %	0.00 %	10.51 %	10.85 %	10.83 %
DIIs	24.49 %	24.86 %	25.00 %	29.73 %	32.41 %	33.31 %	33.29 %	34.03 %	33.55 %	35.19 %	35.05 %	33.79 %	34.37 %	33.78 %	34.23 %
Government	0.28 %	0.22 %	0.22 %	0.24 %	0.24 %	0.24 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	8.74 %	8.25 %	7.61 %	7.75 %	7.79 %	7.50 %	7.44 %	7.41 %	7.26 %	6.98 %	7.14 %	7.12 %	7.13 %	7.27 %	6.93 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,799.10	4,33,931.70	38.70	49,887.20	12.06	9,648	27.34	51.02
Cipla	1,541.95	1,21,755.80	26.38	26,520.70	14.17	4,155	12.95	47.09
Mankind Pharma	2,575.75	1,04,826.50	49.54	10,615.60	19.57	1,942	28.89	52.27
Dr Reddys Laboratories	1,223.80	1,01,936.60	19.09	28,905.40	12.36	5,578	-9.47	42.97
Zydus Life Science	985.25	98,062.50	22.93	19,831.50	13.82	3,831	14.57	48.47
Lupin	2,083.00	94,399.90	35.95	20,141.50	19.94	1,936	73.53	47.09
Aurobindo Pharma	1,248.90	72,876.10	20.17	29,559.20	17.55	3,169	8.66	35.95
Alkem Laboratories	5,637.05	68,065.40	31.30	12,978.40	9.84	1,812	14.16	50.35
Biocon	375.20	45,064.50	32.35	15,621.20	35.25	1,298	-84.31	68.22
Glenmark Pharmaceuticals	1,559.40	43,670.00	-	12,653.10	6.58	-1,831	675.49	44.51